Keppra® Approved By FDA For Childhood Seizures
In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB â�¨declared: â�¨”As a leader in epilepsy UCB has a responsibility to develop effective medicines that address unmet medical needs…
Health News from Medical News Today
This digital document is an article from Internal Medicine News, published by Thomson Gale on May 15, 2006. The length of the arti…
This digital document is an article from NWHRC Health Center – Colon Cancer, published by Thomson Gale on September 7, 2006. The l…
Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of C…
Categories: Colon Cancer Drugs Tags: Approved, childhood, Keppra®, Seizures
